Northwind Pharmaceuticals LLC recalls Valsartan, 160 mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC
Recalled August 22, 2018 · FDA recall D-1095-2018 · Northwind Pharmaceuticals
Hazard
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. · FDA Class II
Units
68 bottles
Sold at
Indiana
Description
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Product
Valsartan, 160 mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-460-52
Manufacturer(s)
Northwind Pharmaceuticals LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →